Fulton Bank’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$576K Buy
8,152
+913
+13% +$49.3K 0.02% 455
2026
Q1
$378K Sell
7,239
-26
-0.4% -$1.56K 0.01% 507
2025
Q4
$427K Sell
7,265
-581
-7% -$35.3K 0.01% 480
2025
Q3
$436K Buy
7,846
+448
+6% +$24K 0.02% 467
2025
Q2
$381K Sell
7,398
-565
-7% -$28.4K 0.01% 483
2025
Q1
$467K Buy
7,963
+1,182
+17% +$80.1K 0.02% 421
2024
Q4
$488K Buy
6,781
+949
+16% +$69.7K 0.02% 420
2024
Q3
$466K Buy
5,832
+13
+0.2% +$977 0.02% 432
2024
Q2
$417K Sell
5,819
-191
-3% -$14.1K 0.02% 432
2024
Q1
$423K Buy
6,010
+566
+10% +$40.5K 0.02% 421
2023
Q4
$420K Buy
5,444
+1,597
+42% +$105K 0.02% 400
2023
Q3
$262K Buy
+3,847
New +$304K 0.01% 488

Other funds holding TECH

Fulton Bank's TECH Position: Q2 2026 in Review

Fulton Bank increased its Bio-Techne (TECH) stake by 13% in Q2 2026, buying an estimated $49.3K and bringing the position to 8,152 shares worth $576K. The position accounts for 0.02% of the portfolio, ranked #455.

Fulton Bank first reported a position in TECH in Q3 2023 and has held it in 12 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Fulton Bank held 8,152 shares of Bio-Techne worth $576K as of Q2 2026.
  • Fulton Bank bought 913 Bio-Techne shares in Q2 2026, an estimated $49.3K.
  • Bio-Techne made up 0.02% of Fulton Bank's portfolio in Q2 2026, its #455 holding.
  • Fulton Bank first reported a position in Bio-Techne in Q3 2023 and has held it in 12 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.